Russell J. Cox
Independent DirectorMr. Russell J. Cox, also known as Russ, has been Independent Chairman of the Board at Spyre Therapeutics, Inc. since January 2019. Mr. Cox served as President, Chief Executive Officer and Director of Empirium Bio, Inc. since January 2020 until January 01, 2025 and serves as its Executive Chairman since January 01, 2025. Mr. Cox served as the Chief Executive Officer and Director of Vital Therapies, Inc. since January 03, 2018 until January 25, 2019. He served as Chief Executive Officer of Immunic, Inc. until January 2019. Mr. Cox has been an Independent Director of Gossamer Bio, Inc. since November 26, 2018. He served as the Chief Operating Officer of Jazz Pharmaceuticals Public Limited Company from May 2014 to January 03, 2018 and its Executive Vice President from March 2012 to January 03, 2018, with responsibility for global commercial activities, research and development, manufacturing and technical operations, new product planning and global molecule leadership. Mr. Cox served as Chief Commercial Officer of Jazz Pharmaceuticals Public Limited Company from March 2012 to May 2014. He served as Senior Vice President at Jazz Pharmaceuticals Public Limited Company and also served as its Senior Vice President of Sales and Marketing from July 2010 to February 2012. He served in a variety of senior management roles since joining Jazz Pharmaceuticals, Inc. (the predecessor to Jazz Pharmaceutical plc) in July 2010. He served as Vice President of HCORP, Inc. He served as Group Product Manager at Genentech, Inc. and Berlex Laboratories. He served as Vice President of Marketing at Jazz Pharmaceuticals, Inc. since July 2010. From January 2009 to January 2010, he was Senior Vice President and Chief Commercial Officer of Ipsen Group, a publicly traded pharmaceutical company and from 2007 to December 2008, he served as Vice President of Marketing at Tercica, Inc. From 2003 to 2007, he was with Scios Inc., where he also held the role of Vice President of Marketing from 2007 to December 2008. Prior to 2003, he was with Genentech, Inc., where he was a Product Team Leader (PTL), responsible for the Growth Hormone franchise and led numerous product launches as a Group Product Manager. He has been a Director of Spyre Therapeutics, Inc. (formerly known as Aeglea BioTherapeutics, Inc.) since June 2015. Mr. Cox has been Executive Chairman of Epirium Bio, Inc. since January 2025, previously having served as its President and Chief Executive Officer from January 2020 to January 2025. Mr. Cox received a B.S. in Biomedical Science from Texas A&M University.
Positions
- Company NameGossamer Bio, Inc.Stock CodeGOSSPositionIndependent DirectorColleagues
- FHFaheem HasnainCo-Founder, CEO, President & Chairman
- BGBryan GiraudoCOO & CFO
- RPRobert Paul SmithChief Commercial Officer
- CWChristian WaageExecutive Vice President, Technical Operations & General Counsel
- JAJeanine AnthonySenior Vice President of Marketing
- SMSandra MilliganIndependent Director
- SDSkye DrynanIndependent Director
- TOThomas O. DanielLead Independent Director
